Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Kai Wang, Quanxin Long, Haijun Deng, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 3, pp. e531-e539
Open Access | Times Cited: 212

Showing 1-25 of 212 citing articles:

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 20, pp. 1920-1931
Open Access | Times Cited: 3212
Evolution of antibody immunity to SARS-CoV-2
Christian Gaebler, Zijun Wang, Julio C. C. Lorenzi, et al.
Nature (2021) Vol. 591, Iss. 7851, pp. 639-644
Open Access | Times Cited: 1584
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow, Carl Graham, Blair Merrick, et al.
Nature Microbiology (2020) Vol. 5, Iss. 12, pp. 1598-1607
Open Access | Times Cited: 1314
Viral targets for vaccines against COVID-19
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1055
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
Jackson S. Turner, Wooseob Kim, Elizaveta Kalaidina, et al.
Nature (2021) Vol. 595, Iss. 7867, pp. 421-425
Open Access | Times Cited: 515
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
Caroline Atyeo, Stephanie Fischinger, Tomer Zohar, et al.
Immunity (2020) Vol. 53, Iss. 3, pp. 524-532.e4
Open Access | Times Cited: 381
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
Stefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 352
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity
Vincent Legros, Solène Denolly, Manon Vogrig, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 2, pp. 318-327
Open Access | Times Cited: 320
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 213
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
Catherine J. Reynolds, Leo Swadling, Joseph M. Gibbons, et al.
Science Immunology (2020) Vol. 5, Iss. 54
Open Access | Times Cited: 205
Evolution of Antibody Immunity to SARS-CoV-2
Christian Gaebler, Zijun Wang, Julio C. C. Lorenzi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 200
Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
Seiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito, et al.
EClinicalMedicine (2021) Vol. 32, pp. 100734-100734
Open Access | Times Cited: 152
Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
Étienne Brochot, Baptiste Demey, Antoine Touzé, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 149
The humoral response and antibodies against SARS-CoV-2 infection
Hai Qi, Bo Liu, Xinquan Wang, et al.
Nature Immunology (2022) Vol. 23, Iss. 7, pp. 1008-1020
Open Access | Times Cited: 144
Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
Josée Perreault, Tony Tremblay, Marie-Josée Fournier, et al.
Blood (2020) Vol. 136, Iss. 22, pp. 2588-2591
Open Access | Times Cited: 139
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice
Natalie Yan‐Lin Pang, Alexander Shao‐Rong Pang, Vincent Chow, et al.
Military Medical Research (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 132
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
Jia Wei, Philippa C. Matthews, Nicole Stoesser, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 118
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
Edwards Pradenas, Benjamin Trinité, Víctor Urrea, et al.
Med (2021) Vol. 2, Iss. 3, pp. 313-320.e4
Open Access | Times Cited: 109
Antibody Response After SARS-CoV-2 Infection and Implications for Immunity
Irina Arkhipova-Jenkins, Mark Helfand, Charlotte Armstrong, et al.
Annals of Internal Medicine (2021) Vol. 174, Iss. 6, pp. 811-821
Open Access | Times Cited: 108
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
Jorge Carrillo, Nuria Izquierdo‐Useros, Carlos Ávila‐Nieto, et al.
Biochemical and Biophysical Research Communications (2020) Vol. 538, pp. 187-191
Open Access | Times Cited: 114
Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study
Gerco den Hartog, Eric R. A. Vos, Lotus L. van den Hoogen, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 12, pp. 2155-2162
Open Access | Times Cited: 90
Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2
Julien Favresse, Constant Gillot, Laura Di Chiaro, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1364-1364
Open Access | Times Cited: 90
Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19
Nico Janssen, Inge Grondman, Aline de Nooijer, et al.
The Journal of Infectious Diseases (2021) Vol. 223, Iss. 8, pp. 1322-1333
Open Access | Times Cited: 79
Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera
Kasopefoluwa Y. Oguntuyo, Christian S. Stevens, Chuan-Tien Hung, et al.
mBio (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 78
Extracellular vesicles carry SARS‐CoV‐2 spike protein and serve as decoys for neutralizing antibodies
Zach Troyer, Najwa Alhusaini, Caroline O. Tabler, et al.
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 8
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top